Ever wondered what happens when a single amino acid, l-tryptophan, decides to hang out in a group? Scientists have been exploring this phenomenon, as it's linked to some nasty metabolic issues. In this fascinating study, researchers watched l-tryptophan transform from a lonely monomer into tiny, glo
Forty years ago, a significant book titled "The Value of Life: An Introduction to Medical Ethics" hit the shelves, shaking up the world of medical ethics. Penned by John Harris, this book has become a cornerstone in the field of bioethics, sparking conversations and debates that continue to this day
Ever wondered why finding new medicines for biliary tract cancer is so hard? It's not just one disease, but a group of different tumors affecting the inside and outside of the liver's bile ducts, and even the gallbladder. Each type has its own genetic make-up, making it a real puzzle for scientists.
Imagine you've had heart surgery as a child and now, as an adult, you need more medical help. That's the case for many people with congenital heart disease. About 20% of them need surgery again in adulthood, and 40% need follow-up procedures from their childhood operations. These surgeries can be to
Brain inflammation, a significant factor in neurodegenerative diseases, is managed by tiny immune cells called microglia. These cells can be pro-inflammatory (M1) or anti-inflammatory (M2). We know that human stem cells from umbilical cords (hUCMSCs) can release substances that reduce inflammation.
Have you ever wondered how to make enzymes stronger and more durable? Scientists have found a clever way to do just that. They've developed a strategy where enzymes are encased in a soft, protective core and a hard shell. This core-shell approach helps enzymes work better and withstand tough conditi
Imagine mixing two different drugs to see what happens. Scientists did exactly that with Albuvirtide (ABT), a new HIV drug, and Rifampicin (RIF), an antibiotic. They gave these drugs to healthy volunteers and checked their blood using advanced lab tests. Turns out, taking RIF with ABT made ABT work
Get ready to meet Jakob Oftebro in a new show called "Vanguard. " This exciting drama tells the story of Swedish media mogul Jan Stenbeck. Viaplay Content Distribution is bringing this series to life, working with FLX and New8 Alliance. The show is directed by Goran Kapetanović and written by Alex H
Bitcoin, the top dog in the cryptocurrency world, has a big problem: it uses a ton of energy and isn't kind to the environment. The proof-of-work system it runs on is to blame. As Bitcoin grows, mining it becomes more popular, especially in places where energy and money costs are low. Researchers de
Bitcoin's skyrocketing value has caught the attention of pension funds, traditionally cautious investors. Even conservative trustees are curious, thanks to bitcoin's dramatic rise last year. Some pension funds in the US and abroad have started dabbling in crypto, hoping to score big returns. Experts
